胃食管反流微创治疗证据现状:范围综述发现
本范围综述评估内镜与微创手术治疗胃食管反流病(GERD)的现有证据量,共纳入22项研究。多数研究显示装置治疗可改善症状与客观指标,不良事件少,但约50%患者酸暴露恢复正常,部分方式长期耐久性不确定。结论认为这些装置是质子泵抑制剂治疗的有前景的替代方案,其治疗地位有待关键临床参数尤其是效果耐久性明确后确定。
要点
- 范围综述纳入22项研究,评估内镜与微创手术治疗GERD的证据。
- 多数研究显示装置治疗改善症状与客观指标,不良事件少。
- 约50%患者酸暴露恢复正常,部分方式长期耐久性不确定。
核心结论
- 内镜与微创手术装置治疗GERD是质子泵抑制剂治疗的有前景的替代方案。
- 其治疗地位有待关键临床参数尤其是效果耐久性更好理解后确定。
研究设计与样本
- 范围综述,采用预设标准进行广泛文献检索,评估内镜与微创手术治疗GERD获益的证据量。
- 优先使用随机对照研究,同时回顾观察性研究数据。
- 共对22项研究进行正式证据审查,记录并列表纳入排除标准和研究时长。
主要发现
- 结局评估基于研究者报告的症状和客观标准,按主观指标(症状评分、生活质量指标、质子泵抑制剂使用变化)和客观指标(pH参数、内镜征象、下食管括约肌压力变化)列表。
- 多数研究显示装置治疗对GERD有症状和客观改善。
- 不良事件极少。
- 约50%患者酸暴露恢复正常,部分方式长期耐久性不确定。
关键数值与推荐
- 范围综述共纳入22项研究进行正式证据审查。
- 约50%患者酸暴露恢复正常。
临床怎么用
- 原文未据此给出推荐。
局限性
- 部分方式长期耐久性不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS & AIMS: Endoscopic management of gastroesophageal reflux disease (GERD) is being employed increasingly. The aim of this scoping review was to assess the volume of available evidence on the benefits of endoscopic and minimally invasive surgical therapies for GERD. METHODS: criteria were used to perform an extensive literature search of data regarding the reported benefit of endoscopic therapies in GERD. Randomized controlled studies were utilized when available; however, data from observational studies were also reviewed. RESULTS: A formal review of evidence was performed in 22 studies. Inclusion and exclusion criteria and study duration were noted and tabulated. Assessment of outcomes was based on symptoms and objective criteria reported by investigators. Reported outcomes for the interventions were tabulated under the heading of subjective (symptom scores, quality of life metrics, and change in proton pump inhibitor use) and objective metrics (pH parameters, endoscopic signs, and lower esophageal sphincter pressure changes). Adverse events were noted and tabulated. The majority of studies showed symptomatic and objective improvement of GERD with the device therapies. Adverse events were minimal. However, normalization of acid exposure occurred in about 50% of patients and, for some modalities, long-term durability is uncertain. CONCLUSIONS: This scoping review revealed that the endoluminal and minimally invasive surgical devices for GERD therapy are a promising alternative to proton pump inhibitor therapy. Their place in the treatment algorithm for GERD will be better defined when important clinical parameters, especially durability of effect, are better understood.
引用
- Vaezi MF, Shaheen NJ, Muthusamy VR, et al. State of Evidence in Minimally Invasive Management of Gastroesophageal Reflux: Findings of a Scoping Review. Gastroenterology. 2020. PMID: 32621903. doi:10.1053/j.gastro.2020.05.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。